News
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...
1d
Pharmaceutical Technology on MSNWegovy and Zepbound costs capped at $200 in new Evernorth programmeEvernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he meant Ozempic or Wegovy.
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...
Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results